Chiron, an AI-driven platform enabling healthcare organisations to deliver personalised care beyond the clinic, has completed a £900,000 seed funding round.

The investment was led by specialist healthcare investor THENA Capital, with participation from Arāya Ventures.

It will support Chiron’s next phase of growth across UK healthcare providers, lay the commercial and regulatory foundations for future expansion into the United States, and further develop its AI platform which empowers people to become active partners in their own care.

Originally spun out of Founders Factory with support from Reckitt, Chiron has received multiple innovation awards and has been recognised as a finalist in global programmes run by Bayer and GSK.